DreaMed Diabetes received FDA 510(k) clearance for MODI, a mobile software tool that uses continuous glucose monitoring data to generate insulin dosing recommendations for people with Type 2 diabetes. The tool is designed for patients on both basal insulin and fast-acting injections, covering a regimen often managed with more frequent dosing decisions.